1. Home
  2. IKNA vs WAI Comparison

IKNA vs WAI Comparison

Compare IKNA & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • WAI
  • Stock Information
  • Founded
  • IKNA 2016
  • WAI 2018
  • Country
  • IKNA United States
  • WAI China
  • Employees
  • IKNA N/A
  • WAI N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • WAI
  • Sector
  • IKNA Health Care
  • WAI
  • Exchange
  • IKNA Nasdaq
  • WAI NYSE
  • Market Cap
  • IKNA 80.8M
  • WAI 87.8M
  • IPO Year
  • IKNA 2021
  • WAI 2023
  • Fundamental
  • Price
  • IKNA $1.71
  • WAI $0.33
  • Analyst Decision
  • IKNA Buy
  • WAI
  • Analyst Count
  • IKNA 2
  • WAI 0
  • Target Price
  • IKNA $3.00
  • WAI N/A
  • AVG Volume (30 Days)
  • IKNA 60.6K
  • WAI 32.9K
  • Earning Date
  • IKNA 11-07-2024
  • WAI 11-29-2024
  • Dividend Yield
  • IKNA N/A
  • WAI N/A
  • EPS Growth
  • IKNA N/A
  • WAI N/A
  • EPS
  • IKNA N/A
  • WAI N/A
  • Revenue
  • IKNA $659,000.00
  • WAI $3,989,698.00
  • Revenue This Year
  • IKNA N/A
  • WAI N/A
  • Revenue Next Year
  • IKNA N/A
  • WAI N/A
  • P/E Ratio
  • IKNA N/A
  • WAI N/A
  • Revenue Growth
  • IKNA N/A
  • WAI N/A
  • 52 Week Low
  • IKNA $1.22
  • WAI $0.19
  • 52 Week High
  • IKNA $2.32
  • WAI $2.14
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 49.85
  • WAI N/A
  • Support Level
  • IKNA $1.71
  • WAI N/A
  • Resistance Level
  • IKNA $1.77
  • WAI N/A
  • Average True Range (ATR)
  • IKNA 0.05
  • WAI 0.00
  • MACD
  • IKNA -0.00
  • WAI 0.00
  • Stochastic Oscillator
  • IKNA 38.46
  • WAI 0.00

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: